19 November 2017
News and Views
Links and Services
A study in May's issue of the Alimentary Pharmacology & Therapeutics investigates the significance of screening for JAK2V617F mutation in Budd–Chiari syndrome and portal venous system thrombosis.
It is important to evaluate whether screening for JAK2V617F mutation should be routinely performe
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors